Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: Quality-of-life findings - SST report no. 14
Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: Quality-of-life findings - SST report no. 14
复制标题
DOI：
10.1016/j.ophtha.2004.07.024
复制
发表时间：
2004-11-01
期刊：
影响因子：
13.7
通讯作者：
Miskala, PH
中科院分区：
文献类型：
--
作者：
Childs, AL;Bressler, NM;Miskala, PH
用途：介绍并比较对参加SST B组试验的患者进行的健康相关生活质量（HRQOL）访谈的结果，该试验评价了与年龄相关性黄斑变性相关的黄斑下脉络膜新生血管病变的手术切除与观察。设计：随机临床试验。符合条件的患者主要为出血性中心凹下脉络膜新生血管病变（总损伤尺寸>3.5个椎间盘区域，血液面积至少为损伤面积的50%，并且赤道后至少有75%的血液）和最佳矫正视力（VA）为20/100，
Purpose: To present and compare findings from health-related quality-of-life (HRQOL) interviews conducted with patients enrolled in the SST Group B Trial evaluating surgical removal of subfoveal choroidal neovascular lesions associated with age-related macular degeneration versus observation.Design: Randomized clinical trial.Participants: Eligible patients had predominantly hemorrhagic subfoveal choroidal neovascular lesions (total lesion size of >3.5 disc areas, area of blood at least 50% of the lesion area, and at least 75% of blood posterior to the equator) and best-corrected visual acuity (VA) of 20/100 to